Novel 2[2-(1,3-diazacycloalk-2-enyl)]benzophenone compounds and novel 1,3-diazacycloalkenyl[2,1-a]isoindole compounds having useful analgesic and psychostimulant properties are prepared inter alia by condensation of o-benzoylbenzaldehydes with aliphatic diamines.
Steroids of the androstane series having a 3.alpha.-hydroxy group, a 3.beta.-hydrogen or methyl group; a 10-hydrogen atom or methyl group, an 11-oxo group or two hydrogen atoms at the 11-position, a 17.alpha.-hydrogen atom, and a group at the 17.beta.-position which is esterified carboxyl group, an N-mono or di-substituted carbamoyl group, a cyano group, a formyl group or an acetalised formyl group; and the 3.alpha.-esters thereof. The steroids possess anaesthetic properties.
Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
申请人:ZENECA LIMITED
公开号:US20030207882A1
公开(公告)日:2003-11-06
Compounds of formula (I), wherein G
1
is CH or N; G
2
is CH or N; R
1
is a variety of optional substituents, L
1
is (1-4C)alkylene; T
1
is CH or N; R
2
and R
3
are independently hydrogen or (1-4C)alkyl or are joined to form a ring; X
1
and X
2
represent various linking groups; Ar is phenylene or certain heteroaryl rings and Q represents a variety of aromatic or heterocyclic rings systems, and pharmaceutically acceptable salts thereof are described as useful antithrombotic and anticoagulant agents, and are selective Factor Xa inhibitors. Processes for their preparation and pharmaceutical compositions containing them are also described.
1
Process for the preparation of certain hydroperoxy derivatives
申请人:Hoffmann-La Roche Inc.
公开号:US04018765A1
公开(公告)日:1977-04-19
Novel 2[2-(1,3-diazacycloalk-2-enyl)]benzophenone compounds and novel 1,3-diazacycloalkenyl[2,1-a]isoindole compounds having useful analgesic and psychostimulant properties are prepared inter alia by condensation of o-benzoylbenzaldehydes with aliphatic diamines.
Thienyl benzothienyl and dibenzothienyl compounds as inhibitors of
申请人:Imperial Chemical Industries PLC
公开号:US05102905A1
公开(公告)日:1992-04-07
The invention concerns heterocyclic nitromethane derivatives of the formula 1 as defined hereinafter (and their non-toxic salts) wherein the heterocyclic moiety Q is thienyl, benzothienyl or dibenzothienyl and may bear a wide variety of optional substituents, together with pharmaceutical compositions containing them. The nitromethane derivatives are inhibitors of the enzyme aldose reductase and are of value in the treatment of certain complications of diabetes and galactosemia.